Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death

Mizuyo Nakamura(Chiba Cancer Center), Toshinori Ozaki(Chiba Cancer Center)

Oncogenesis

June 13, 2016

10.1038/oncsis.2016.40

Cited by 20

Related Papers

Role of p53 in Cell Death and Human Cancers

|Cancers|2011|728

Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage

|Cell Death and Disease|2013|89

Depletion of pro-oncogenic <i>RUNX2</i> enhances gemcitabine (GEM) sensitivity of <i>p53</i>-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63

|Oncotarget|2016|14

<scp>PTPRK</scp> suppresses progression and chemo‐resistance of colon cancer cells via direct inhibition of pro‐oncogenic <scp>CD</scp>133

|FEBS Open Bio|2019|14

Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63

|PLoS ONE|2017|11